235 filings
Page 5 of 12
8-K
8u2rq0g ua5hyc45yw0
21 Apr 20
Other Events
5:05pm
8-K
tz82f 35cjk0omlnuz
3 Apr 20
Departure of Directors or Certain Officers
5:00pm
8-K
m7syx0778
20 Mar 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:00pm
8-K
9d38 ylxwi9v
13 Mar 20
ADMA Biologics Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Company Progress
12:00am
8-K
x1m83qf14ibz4du7kg
5 Mar 20
Departure of Directors or Certain Officers
4:10pm
8-K
ui6e0 h1y
24 Feb 20
Other Events
7:30am
8-K
4mx1uq5d
11 Feb 20
Other Events
4:30pm
8-K
1b9xmfk5
11 Feb 20
Other Events
4:05pm
8-K
0x6 m98wjz
7 Feb 20
ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock
4:05pm
8-K
bwi5kxrcncfr
13 Jan 20
Regulation FD Disclosure
7:00am
8-K
04mdrje
9 Jan 20
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2019 Revenues and Provides 2020 Strategic Outlook
7:30am
8-K
gha433mep9qq
7 Jan 20
ADMA Biologics Enters Into a Manufacturing and Supply Agreement to Produce and Sell Plasma-Derived Intermediate Fractions
7:30am
8-K
gxyka
17 Dec 19
Departure of Directors or Certain Officers
7:38am
8-K
mje3228vp6nwdzcf
19 Nov 19
Regulation FD Disclosure
5:18pm
8-K
8t3b5axpjjpbwb4zn
13 Nov 19
ADMA Biologics to Present at Jefferies 2019 London Healthcare Conference
7:18am
8-K
zgkaaudj
6 Nov 19
ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress
5:11pm
8-K
v7r87d1sa tehbfsn
22 Oct 19
ADMA Biologics Named Company of the Year by BioFlorida
7:58am
8-K
uknljlts09hm ht7yb
21 Oct 19
Other Events
7:58am
8-K
pymhv xv1
17 Oct 19
ADMA Biologics Announces Publication of an
7:49am
8-K
n44j5ugikhhls yhygk
7 Oct 19
ADMA Biologics Announces Data Presented at IDWeek 2019
7:28am